Friderichs E
Arzneimittelforschung. 1982;32(6):613-20.
CNS activity of thalidomide was compared with that of 5 analogs modified in the phthalimide or 2,6-dioxopiperidine moiety. All compounds had a qualitatively comparable profile of CNS-depressant actions. In low dosages spontaneous motor activity was depressed, threshold of barbiturate anaesthesia was lowered, and isolation-induced aggression was inhibited. All compounds suppressed tonic convulsions induced by maximum electroshock. Only at high dosages muscle tone and body temperature were lowered. Protection against nicotine lethality revealed antagonistic activity at central nicotinergic synapses. Corresponding depression of peripheral ganglionic transmission was indicated by mydriatic and antidiarrhoeal activity. While thalidomide, supidimide, EM 8, and EM 255 did not induce anaesthesia up to highest or lethal-toxic doses, EM 136 and EM 12 in accordance with common sedative-hypnotic drugs induced loss of righting reflex at high dosages. EM 136 differs from thalidomide only in that one oxygen group at the piperidine moiety is missing. This finding indicates that a minor structural change shifts CNS depression towards anaesthetic properties. A clearcut relation between structure and teratogenic activity had been established in this group of compounds, whereas CNS-depressant efficacy could not be unequivocally related to particular structural features.
将沙利度胺的中枢神经系统活性与其在邻苯二甲酰亚胺或2,6 - 二氧代哌啶部分修饰的5种类似物的活性进行了比较。所有化合物在中枢神经系统抑制作用方面具有定性可比的特征。在低剂量时,自发运动活性受到抑制,巴比妥类麻醉的阈值降低,隔离诱导的攻击行为受到抑制。所有化合物都能抑制最大电休克诱导的强直性惊厥。仅在高剂量时,肌张力和体温才会降低。对尼古丁致死性的保护作用显示在中枢烟碱能突触处具有拮抗活性。散瞳和止泻活性表明外周神经节传递相应受到抑制。虽然沙利度胺、舒必利胺、EM 8和EM 255在最高或致死毒性剂量下都不会诱导麻醉,但EM 136和EM 12与常见的镇静催眠药物一样,在高剂量时会导致翻正反射消失。EM 136与沙利度胺的不同之处仅在于哌啶部分缺少一个氧基团。这一发现表明,微小的结构变化会使中枢神经系统抑制作用向麻醉特性转变。在这组化合物中已经确立了结构与致畸活性之间的明确关系,而中枢神经系统抑制功效与特定结构特征之间并无明确关联。